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In traditional Chinese medicine (TCM), diagnosis of pathology and choice of treatment prescriptions are based on a method
of diﬀerentiation of signs and symptoms known as syndrome diﬀerentiation or ZHENG. The cornerstone of TCM, ZHENG,
relies on the gathering of clinical information through inspection, auscultation and olfaction, inquiry, and palpation. However,
the biomolecular basis of the ZHENG remains unclear. In this study, we established mouse xenograft pancreatic cancer models
with Shi-Re (Dampness-Heat), Pi-Xu (Spleen-Deﬁciency), or Xue-Yu (Blood-Stasis) ZHENG, which are regarded as the three
major ZHENGs in pancreatic cancer. We found that tumors of the diﬀerent ZHENG models exhibited signiﬁcantly altered cancer-
associated ﬁbroblast (CAF) proliferative activity and tumor-associated macrophage (TAM) inﬁltration, which led to altered levels
of CAF- and TAM-derived secreted cytokines such as SDF-1 and CCL5. The ZHENG model type also signiﬁcantly inﬂuenced
tumor growth, and administration of herbal medicine to the ZHENG model modiﬁed the tumor microenvironment. Therefore,
this study partially unveiled the molecular basis of TCM ZHENG in pancreatic cancer.
1.Introduction
Traditional Chinese medicine (TCM) has a history of over
3000 years. A holistic form of medicine, TCM, emphasizes
bringing the patient’s body, mind, and spirit into harmony.
The theory and application of TCM are one of constant
summarizing,inducing,andreﬁningoftheexperiencesaccu-
mulated in preventing and treating diseases in daily life and
medical practice.
TCM rests squarely on ZHENG (syndrome) diﬀerenti-
ation, a process of analyzing data collected through four
combined diagnostic methods: inspection, auscultation and
olfaction, inquiry, and palpation. All diagnostic and thera-
peutic methods in TCM are based on the diﬀerentiation of
ZHENG. In modern times, TCM has become popular world-
wide because of its reliable therapeutic eﬃcacy [1]. However,
diagnosis in TCM depends on the intuition and experience
of the physician grounded in TCM theory, and this method
seems to lack objectivity, accuracy, and reproducibility in the
face of biomolecular science and Western-based medicine.
Furthermore, the concept of ZHENG is often misinterpreted
and unclear. For all these reasons, researchers from China
and elsewhere have begun to investigate the ZHENG of TCM
for a molecular foundation.
Tumors are now recognized as structures of multiple cell
types, comparable to organs in complexity, which during
tumorigenesis recruit the involvement of surrounding nor-
malcellstoconstructandinteractwithinatumormicroenvi-
ronment [2]. Continuous paracrine signaling with feedback
within this microenvironment eventually leads to the end
stages of cancer progression [3]. As cancer is no longer
considered a discrete entity deﬁned only by the traits of
cancer cells within the tumor but may eventually involve the
entire organism, TCM oﬀers a holistic approach whose goal
is regulating the integrity of all body functions as well as the
interaction between the human and surrounding environ-
ment.
We have previously shown that the presence of ZHENG
may inﬂuence tumor growth in pancreatic cancer. We also
found that this eﬀectmight correlate with the CC chemokine2 Evidence-Based Complementary and Alternative Medicine
(β-chemokine) family [4]. This ﬁnding suggests an involve-
ment between ZHENG and the tumor microenvironment
and deserves further research. Accordingly, in the present
study we evaluated the tumor microenvironment under
diﬀerent ZHENG conditions, speciﬁcally noting changes
in the proliferative activity of cancer-associated ﬁbroblasts
(CAF) and the inﬁltration of tumor-associated macrophages
(TAM). We conﬁrm here that characteristics of the tumor
environment correlated with the ZHENG of TCM, and
herbal treatments modiﬁed the tumor microenvironment.
2.MaterialsandMethods
2.1. Cell Lines and Mice. Samples of the pancreatic cancer
cell line Panc02 were obtained from the Cancer Research
and Development Center and grown in complete growth
mediumasrecommendedbythemanufacturer.Thecultured
cells were maintained in a humidiﬁed 5% CO2 atmosphere
at 37◦C. All cells were regularly authenticated by observing
cell morphology and tested for the absence of mycoplasma
contamination using a MycoAlert Mycoplasma Detection kit
(MycoAlert, Lonza, Rockland, ME, USA).
Male C57 mice, 4- to 6-week old, were obtained from
the Shanghai Institute of Materia Medica at the Chinese
Academy of Sciences (Shanghai, China) and housed in lam-
inar ﬂow cabinets under speciﬁc pathogen-free conditions
with food and water supplied ad libitum.A l le x p e r i m e n t s
on mice were conducted in accordance with the guidelines
of the National Institutes of Health (NIH) for the Care and
Use of Laboratory Animals. The Committee for the Use of
Live Animals in Teaching and Research, Fudan University,
Shanghai approved the study protocol.
2.2. Drugs and Reagents. Individual packets of herb powders
for each herb were produced by Jiangyin Tianjiang Phar-
maceutical. The ﬁnal decoction of each prescription was
prepared at the Department of Pharmacy, Fudan University
Shanghai Cancer Center, Shanghai, China, by dissolving the
herb powder into distilled water to the required concentra-
tion. The daily dosage of herb decoctions for the mice was
calculated according to the following human-mouse transfer
formula: Db = Da × (Rb/Ra) × (Wb/Wa)2 /3, where
D, R,a n dW represent dosage, shape coeﬃcient, and body
weight, respectively, and a and b represent human mouse,
respectively.
HoneysuppliedbyGuanShengYuanInternationalTrade
(Shanghai) was adjusted to a concentration of 20% in
water. Wine (er guo tou) obtained from Hongxing (Beijing)
was diluted to 55% in water. Pork fat was donated by
Gu Jianzhong, Chinese Academy of Sciences (Shanghai).
The following antibodies were used: anti-vimentin, anti-α-
smooth muscle actin (SMA), anti-C-X-C chemokine recep-
tortype4(CXCR4),andanti-C-Cchemokinereceptortype5
(CCR5;allfromEpitomics),andanticlusterofdiﬀerentiation
68 (CD68; Santa Cruz Biotechnology, Santa Cruz, CA).
2.3. Establishment of TCM ZHENG Model. We developed
three types of TCM ZHENG models in respective mouse
groups, namely, Shi-Re (Dampness-Heat), Pi-Xu (Spleen-
Deﬁciency), and Xue-Yu (Blood-Stasis). The Shi-Re and
Pi-Xu ZHENG models were established as we described
previously [4]. Brieﬂy, the Shi-Re condition was established
by the wine and the pork fat combination (day 1 to day
7, 0.2mL), and the food and honey-water were provided.
Pi-Xu was developed by feeding the mice with a decoction
of mirabilite and Chinese rhubarb, 0.2mL for each mouse
( d a y1t od a y7 ) .T h eXue-Yu ZHENG was established by
subcutaneous injection of 0.01% adrenaline (0.13mg/kg) for
each mouse (day 1 to day 7), as we described previously [5].
2.4. Subcutaneous Xenograft Tumor Model. Panc02 cells (2 ×
106 cells in 200μL) were injected subcutaneously into the
r i g h ta x i l l ao fe a c hC 5 7m o u s e .T h el e n g t ha n dw i d t ho f
tumors (in millimeters) were measured weekly with calipers.
Tumor volume was calculated by the formula (a × b2) ×
0.5, where a and b were the long and short dimensions,
respectively. Mice were euthanized under anesthesia when
tumors reached 1.5cm in diameter. The tumors were then
resected and weighed. Each group had ≥10 mice.
2.5. Immunohistochemical Analysis. Specimens of tumor
tissue were ﬁxed in 10% formalin and embedded in paraﬃn
wax. Unstained 3μm sections were then cut from paraﬃn
blocks for immunohistochemical (IHC) analysis. The sec-
tions were stained with rabbit anti-vimentin (1:100), rabbit
anti-α-SMA (1:100), rabbit anti-CD68 (1:200), rabbit anti-
CXCR4(1:200),andrabbitanti-CCR5at4◦Covernight.The
secondary antibody and avidin-biotin peroxidase complex
method was used according to the standard protocols
provided by the manufacturer (Vector Laboratories, CA,
USA). An immunoglobulin-negative control was used to
rule out nonspeciﬁc binding. Two independent assessors
and one pathologist performed all procedures, all of whom
were blinded to the model/treatment type for this series of
specimens.
To quantitatively evaluate the CAF proliferative activity
and TAM inﬁltration in each group, we calculated the ratio
of the area positive for vimentin or CD68 staining to the
total area in histological sections from ten ﬁelds under light
microscopy (200x). The procedure for evaluation of CXCR4
and CCR5 expression followed that of our previous report
[4].
2.6. Enzyme-Linked Immunosorbent (ELISA) Assay for Cytok-
ine Release. The concentrations of SDF-1 and CCL5 in the
tumor samples were determined using a sandwich ELISA kit
(DuoSet; R&D Systems, Minneapolis, MN) according to the
protocol of the manufacturer. Brieﬂy, frozen tumor tissue
was homogenized in lysis buﬀer and thereafter centrifuged at
12,000rpm for 15 minutes at 4◦C; 50μL of the supernatant
was used for ELISA. Concentrations of immunoreactive
SDF-1 and CCL5 were expressed as pg/mL.
2.7. Statistical Analyses. The data are expressed as the
mean ± standard error (SE) of three or more independent
experiments performed in triplicate. The statistical analysesEvidence-Based Complementary and Alternative Medicine 3
were performed using analysis of variance (ANOVA) models
and Student’s t-tests. A P value <0.05 was accepted as statis-
tically signiﬁcant.
3. Results
3.1. ZHENG Distribution in Pancreatic Cancer Patients. We
ﬁrstly investigated the distribution of ZHENG conditions in
populations of pancreatic cancer patients based on reports
published from January 1, 1998 to December 31, 2008.
Sixty-nine studies were identiﬁed by electronic and hand
searches, among which 34 clinical articles were included
for our study. Data on ZHENG distribution were extracted
and analyzed. Twenty-seven ZHENGs were identiﬁed. The
three ZHENGs in pancreatic cancer that were most reported
were Dampness-Heat (in Chinese, Shi-Re; 33.9% of studies),
Spleen-Deﬁciency (Pi-Xu; 29.10%), and Blood-Stasis (Xue-
Yu; 19.8%; Figure 1).
3.2. Alteration of Tumor Microenvironment under Diﬀerent
ZHENG Conditions. The tumor microenvironment plays
an important role in the development and progression of
cancer [6, 7]. Pancreatic carcinomas are surrounded by
desmoplastic stroma consisting of ﬁbroblasts, immune cells,
endothelial cells, and pericytes [8]. We hypothesized that the
tumor microenvironment would be altered under diﬀerent
ZHENG conditions. To verify this hypothesis, we ﬁrst estab-
lished 3 subcutaneous tumor models of pancreatic cancer
in mice that exempliﬁed the ZHENG conditions Shi-Re, Pi-
Xu,a n dXue-Yu, respectively. We sought to investigate the
diﬀerences in the tumor microenvironment among these
ZHENG models.
As it is recognized that in many tumors the stroma is
characterized by an increase in ﬁbroblast proliferation, we
immunostainedCAFsusingtheﬁbroblasticmarkervimentin
combined with the deﬁned myoﬁbroblast marker α-smooth
muscle actin (α-SMA) to investigate the proliferative activity
ofCAF[9].Wefoundthatthenumberofbothvimentin-and
α-SMA-positive cells was decreased in tumors from the Shi-
Re andPi-XuZHENGmodelsofpancreaticcancercompared
withthecontroltumor,whiletumorsfromtheXue-Yu model
exhibited no changes in CAF activity (Figures 2(a) and 2(b)).
This observation suggested that CAF proliferative activity
in tumors was altered diﬀerently on the basis of ZHENG
conditions.
It is accepted that, in general, cancer- and host-cell-
derived signals program TAMs to acquire an M2-like polar-
ized and otherwise tumor-supportive phenotype [10]. In
many cases increased numbers of TAMs are associated with a
poorer prognosis [11, 12]. Therefore, we evaluated tumors in
thediﬀerentZHENGmodelsforTAMinﬁltrationbystaining
forCD68(alsoknownasmacrosialininmice),aglycoprotein
expressed on macrophages. We found that, compared with
the control group, the number of macrophages was dramat-
ically less in the Shi-Re group, followed by lesser degrees of
decrease in the Pi-Xu groups (Figures 2(a) and 2(b)). This
observation suggests relatedness between the inﬂammation
characteristics of tumor microenvironments and the speciﬁc
Others
17.2% (Dampness-Heat)
33.9%
(Spleen-Deﬁciency)
29.1%
(Blood-Stasis)
19.8%
Shi-Re
Pi-Xu
Xue-Yu
Figure 1:Percentages ofpancreaticpatientsdiagnosedwithvarious
TCM ZHENG conditions. Data on ZHENG distribution were
extracted and analyzed from 34 clinical articles published between
January 1, 1998 and December 31, 2008.
ZHENG conditions tested. Altogether, our study demon-
strated a correlation between ZHENG conditions and the
microenvironment of tumors in pancreatic cancer.
3.3. Correlation between Tumor Microenvironment and
Growth under Diﬀerent ZHENG Conditions. CAFs stimu-
late tumor cell proliferation and invasion through various
growth factors, hormones, and cytokines [13]. SDF-1 is a
CAF-derived chemokine that has been shown to directly
boost the proliferation and invasion of pancreatic cancer
cells [14]. Thus, we evaluated the levels of secreted SDF-
1 in tumors under diﬀerent ZHENG conditions, and the
expression of CXCR4, the SDF-1 cognate receptor, in tumor
cells. The results of ELISA assays showed decreased levels of
S D F - 1r e l e a s e di nt u m o r si nt h eShi-Re and Pi-Xu groups
compared to the control mice. This was not observed in the
Xue-Yu tumors (Figure 3(a)). This result was consistent with
the observation that the Shi-Re and Pi-Xu tumors exhibited
decreased CAF proliferative activity. However, there was no
diﬀerence in CXCR4 expression among the ZHENG models
and control tumor cells (Figures 3(b) and 3(c)).
Similarly, we wanted to verify whether the decreased
TAM inﬁltration we observed above led to a reduction in
the levels of the TAM-derived cytokine CCL5. We found that
secreted CCL5 decreased dramatically in tumors under Shi-
Re and Pi-Xu ZHENGs. This was also observed in the Xue-
Yu tumors, although the diﬀerence was not signiﬁcant (P =
0.083) (Figure 3(a)). We also found that tumor cells from the
Shi-Re, Pi-Xu, and Xue-Yu models exhibited decreased CCR5
expression, especially for Shi-Re (Figures 3(b) and 3(c)).
After we conﬁrmed that CAF-related SDF-1/CXCR4
and TAM-related CCL5/CCR5 expressions were changed
under diﬀerent ZHENG conditions, we next investigated an
association between the altered tumor microenvironments
and tumor growth. We found that altered tumor microen-
vironments were correlated with in vivo changes in tumor
growth (Figure 3(d)). Taken together, these results suggest
that tumors under diﬀerent ZHENG conditions exhibited
diﬀerent tumor microenvironments, which may ﬁnally eﬀect
tumor growth.4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Alterations of tumor microenvironments under diﬀerent ZHENG conditions. (a) Xenograft tumor models were established as
described. On the next day, three types of ZHENG,n a m e l y ,Shi-Re, Pi-Xu,a n dXue-Yu were established. Tumors were obtained 4wks after
implantation. IHC staining for vimentin and α-SMA on sections of tumors was performed for evaluating CAF proliferative activities (top).
IHC staining for CD68 was performed for evaluating TAM inﬁltration (low). Original magniﬁcation, 200x. (b) CAF proliferative activity
(left) and TAM inﬁltration (right) were quantitatively evaluated by calculating the ratio of vimentin or CD68 antibody positive staining area
to the total area in each ﬁeld, and the mean value from ten ﬁelds under 200x microscopy was indicated. ∗P<0.05; ∗∗P<0.01; n.s.: not
signiﬁcant.
3.4. Tumor Response under Diﬀerent ZHENG Conditions to
Herbal Medicine Treatments. TCM usually means a com-
prehensive assessment of pathogenesis, location, and disease
pathology, and the diagnosed ZHENG helps guide the
application of Chinese herbal remedies. So, we used Huang
lian jie du decoction (a traditional prescription used of
treating Shi-Re ZHENG), Si jun zi decoction (a traditional
prescription used of treating Pi-Xu ZHENG), and Tao hong
si wu decoction (a traditional prescription used of treating
Xue-Yu ZHENG)f o rShi-Re, Pi-Xu, and Xue-Yu tumors,
respectively. The herbal prescriptions used are shown in
Table 1. We found that the herbal medicines had no or little
eﬀectonCAFproliferationorTAMinﬁltration(Figure 4(a)).
We also evaluated the eﬀects of the herbal medicines on
SDF-1 secretion and CCL5 levels and found that the levels
of which did not change after herbal medicine treatment
(Figure 4(b)). Similarly, none of the herbal medicines had
signiﬁcant eﬀects on CXCR4 or CCR5 expression in tumor
cells (Figure 4(c)). These observations indicated that the
herbal medicines had little eﬀect on either the tumor orEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: Correlation between microenvironment and tumor growth under diﬀerent ZHENG conditions. (a) The levels of CAF- and TAM-
derived secreted cytokines, SDF-1 and CCL5, in tumor from the Shi-Re, Pi-Xu,a n dXue-Yu ZHENG models were evaluated with ELISA
assay. Data are expressed as the mean ± SE. (b and c) IHC staining for CXCR4 and CCR5 on sections of tumors from ZHENG models was
performed and representative photos are shown in (b). The positive rates of CXCR4 and CCR5 protein in tumors with indicated ZHENG
are shown in (c). (d) Eﬀect of ZHENG on tumor growth in a subcutaneously transplanted tumor model. Xenograft tumor model combined
withZHENG modelwasestablishedasdescribedinFigure 2(a). Mean volumes of tumorsfromeach group weremeasured. Mean ±standard
deviation was determined for 10mice in each group.
microenvironment. Finally we evaluated the eﬀects of the
herbal medicines on tumor growth and could not ﬁnd
any diﬀerence when the tumors were treated with diﬀerent
typesofherbalmedicine(Figure 4(d)).Therefore,ourresults
suggest that a prescription based solely on ZHENG does not
always result in a satisfactory response.
3.5. Herbal-Medicine-Induced Alteration of Tumor Microen-
vironment Is Correlated with Treatment Response. Although
tumors under diﬀerent ZHENG conditions demonstrated
diﬀerences in tumor microenvironment which may ﬁnally
be reﬂected in tumor growth, the ZHENG conditions them-
selves seemed not to promote tumor growth. Thus, herbal
medicines prescribed on the basis of the ZHENG condition
alonedidnotaﬀecttumorgrowth.Tofurtherunderstandthe
relatedness of tumor microenvironment, ZHENG, and the
response to herbal treatment, we employed the Qingyihuaji
formula (QYHJ), a prescription based on TCM theory
whereby pancreatic cancer is considered to be of Shi-Re
origin. QYHJ has been used to treat pancreatic cancer for6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Treatment response to herbal medicine involved with modiﬁcation of tumor microenvironment. (a) The antitumor eﬀect of
Qingyihuaji formula (QYHJ) on tumor with diﬀerent ZHENG.( b )T h ee ﬀect of QYHJ on CAF proliferative activities and TAM inﬁltration
wereevaluatedasdescribedinFigure 2.(c)TheeﬀectofQYHJonsecretedSDF-1andCCL5levelswereevaluatedasdescribedinFigure 3(a).
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Table 1: Herbal prescriptions used in this study.
Prescription Contents (g)
Huang lian jie du decoction Coptis root (9), baical skullcap root (6), amur corktree bark (6), cape jasmine fruit (9)
Si jun zi decoction Ginseng (9), largehead atractylodes rhizome (9), poria (9), liquorice root (6)
Tao hong si wu decoction Peach seed (9), saﬄower (6), Chinese angelica root (9), rehmannia root (12), rhizome of szechwan lovage
(6), radix paeoniae rubra (9)
Qingyihuaji formula Herba scutellariae barbatae (15), hedyotidis herba (15), amorphophallus konjac (15), coix seed (15),
ﬁveleaf gynostemma herb (15), java amomum fruit (10)
many years [15, 16]. We ﬁrst established mouse tumor
models with the accompanying ZHENG conditions Shi-Re,
Pi-Xu,a n dXue-Yu. The mice were then treated with QYHJ
and the tumor microenvironment and tumor growth were
evaluated. We found that tumors of the diﬀerent ZHENG
condition models exhibited altered tumor microenviron-
ments (Figures 5(b) and 5(c)), which is consistent with
our previous observations (Figure 2). The QYHJ treatments
altered the tumor microenvironments in the Shi-Re, Pi-Xu,
Xue-Yu models dramatically, as demonstrated by decreased
CAF proliferation and TAM inﬁltration (Figure 5(b) and
5(c)). Then when we correlated tumor microenvironment
alteration with tumor growth, we surprisingly found that
QYHJ treatment led to growth inhibition of tumors under
diﬀerent ZHENG conditions, although the inhibition rate
varied among the diﬀerent ZHENG (Figure 5(a)). This
suggests that disease identiﬁcation is sometime a requisite
for the treatment of cancer with TCM. Taken together,
these results indicate that a combination of disease diagnosis
and ZHENG identiﬁcation is essential for clinical TCM
practice in cancer treatment. They also showed a relatedness
betweenthetumorenvironmentandZHENG,andtreatment
response to herbal medicine involved the modiﬁcation of the
tumor microenvironment.
4. Discussion
In this study, we established three diﬀerent ZHENG mouse
models according to TCM theory. We identiﬁed alterations
in the tumor microenvironment under diﬀerent ZHENG
conditions. These tumor microenvironment modiﬁcations
mediated a correlation between the ZHENG condition and
response to herbal treatment. Therefore our study revealed a
molecular basis for ZHENG in pancreatic cancer.
InTCMclinicalpractice,ZHENGhelpsguidetheremedy
prescription and therefore has an important position in the
TCM system, that is, ZHENG is the key to recognizing dis-
eases and the foundation to treat them. However, because of
thecomplexityoftheconcepts(e.g.,asingleZHENGinvolves
multiple anatomical systems) and lack of nonprofessional
descriptions, research of ZHENG is diﬃcult to advance.
The molecular basis underlying ZHENG in TCM remains
unclear.
It has been conﬁrmed that tumor cells do not act in
isolation, but rather subsist in a rich microenvironment pro-
vided by resident ﬁbroblasts, inﬂammatory cells, endothelial
cells, pericytes, leukocytes, and extracellular matrix [17]. It
is increasingly appreciated that, as the cancer progresses,
the surrounding microenvironment is activated in support,
coevolving through continuous paracrine communication
and supporting carcinogenesis [3]. Pancreatic ductal adeno-
carcinoma is characterized by an extensive stromal response
called desmoplasia. Within the tumor stroma, CAFs are the
primary cell type; the importance of the role of CAFs in
tumor progression is now well accepted. CAFs produce large
amountsofsecretedfactors,includingCXC,CCchemokines,
and other inﬂammatory mediators that promote the pro-
liferation, invasion, and metastasis of cancer cells [18]. It
is also accepted that large numbers of tumor-associated
leukocytes inﬁltrate solid tumors, and TAMs represent a
major and important component of these leucocytes, which
are driven toward functions that support cancer progression
and poorer prognosis [12]. Therefore the stromal elements
of tumors hold prognostic, as well as response-predictive,
information. Abundant targeting opportunities within the
tumor microenvironment are continually identiﬁed [3].
As TCM sustains systematic theories and is a holistic
approach to health, and our previous study has indicated a
correlation between ZHENG and levels of cytokines related
to CAF and TAM [4], we hypothesized a correlation between
the tumor microenvironment and the ZHENG syndromes of
TCM. Thus we evaluated the tumor microenvironment by
immunostaining for CAF and TAM and surprisingly found
diﬀerences in microenvironment alterations under diﬀerent
ZHENG conditions. Furthermore, the alterations in CAF
proliferative activity and TAM inﬁltration led to changed
levels of CAF- and TAM-derived secreted cytokines which
ﬁnally aﬀected tumor growth.
Based on TCM theory and clinical experience, patients
with pancreatic cancer usually exhibit Shi-Re, Pi-Xu,o r
Xue-Yu, and respective herbal decoctions for removing heat
and dampness (Huang lian jie du), reinforcing Qi and
strengthening the spleen (Si jun zi), and promoting blood
circulation and removing blood stasis (Tao hong si wu)a r e
always prescribed. However the eﬃcacy of these remedies
is not always satisfactory. In the current study, the appli-
cation of decoctions of these herbal medicines had little
eﬀect on tumor growth or the tumor microenvironment.
This observation seems to contradict the TCM theories of
treating the same disease with diﬀerent methods and treating
diﬀerent diseases with the same methods. There are many
reasonsthatmayaccountforthelackofresponsetotheTCM
treatments in the present study. One is that each prescriptionEvidence-Based Complementary and Alternative Medicine 9
has its priority and focus, although they are within the
same category for the same ZHENG. Another reason is
that apart from the traditional relationship between disease
and ZHENG, there may also exist analogous ZHENG in
the same disease, which means that diﬀerent patients who
suﬀer from the same disease manifest the common basic
ZHENG in spite of slight diﬀerences in their accompanying
symptoms. Therefore, we can use a basic prescription with
slight modiﬁcations to treat accompanying symptoms. In
fact recent research emphasized the principle of analogous
ZHENG existing in the same disease in TCM clinical
practice [19], especially in cancer treatment. These two
reasons may partially explain why the prescriptions based on
ZHENG used in the present study had little eﬀect on tumor
growth.
The integration of disease diagnosis and identiﬁcation
of ZHENG have been widely used in cancer treatment
[20]. Based on our previous studies, pancreatic cancer is
characterized by dampness, heat, and toxicity and should
be treated by removing heat and dampness, detoxiﬁcation
and resolving a mass [21]. According to this recognition,
we recommend the QYHJ formula in the treatment of
pancreatic cancer. The results of our clinical studies suggest
that treatment with QYHJ resulted in prolonged survival
time for patients with pancreatic cancer [15, 21]. Animal
studies showed that QYHJ could inhibit the growth of
subcutaneouslytransplantedpancreatictumorsinnudemice
[16]. Just as we can see from this study, QYHJ had an
eﬀect on tumor growth and the tumor microenvironment,
although the eﬀect varied depending on the ZHENG type.
Therefore, our study suggests an intrinsic disease-speciﬁc
ZHENG, which should be considered during TCM practice.
The study also indicated that the tumor microenvironment
inﬂuences the tumor response to herbal medicine treatment.
In conclusion, our study showed alterations in the tumor
microenvironment under diﬀerent ZHENG conditions. We
alsoconﬁrmedarelatednessbetweenthetumorenvironment
and ZHENG, and herbal medicine treatments modiﬁed the
tumor microenvironment. This study partially unveiled the
molecular basis of TCM ZHENG in pancreatic cancer.
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